online shoes store xkshoes,here check the latest yeezy shoes click here.

know more about 2020 nike and adidas soccer cleats news,check shopcleat and wpsoccer.

online shoes store xkshoes,here check the latest yeezy shoes click here.

know more about 2020 nike and adidas soccer cleats news,check shopcleat and wpsoccer.

About Masroor A. Khan, M.D., FACC, FSCAI

Preventive Cardiology Services | Dr. Masroor Khan
7/1998 – 6/1999 Interventional Cardiology Fellowship, University of Alabama at Birmingham

7/1995 – 6/1998 Cardiology Fellowship, Illinois Masonic Medical Center, Chicago, IL

7/1992 – 6/1995 Internal Medicine Residency, Wayne State University, Detroit, MI

10/1990 – 9/1991 Internship in Medicine & Surgery, Civil Hospital, Karachi, Pakistan

12/2005 – 08/2010 Associate Professor of Medicine, University of Texas Health Science Center at Tyler

5/2000 – 12/2005 Assistant Professor of Medicine, University of Texas Health Science Center at Tyler

8/1998 – 4/2000 Associate Fellow, University of Alabama at Birmingham>
9/2010 – Present Memorial Herman Medical Center, Houston, Texas

9/2010 – Present Park Plaza Hospital, Houston, Texas

9/2010 – Present The Methodist Hospital, Houston, Texas

9/2010 – Present St. Lukes Episcopal Hosptial, Houston, Texas

1/2006 – 8/2010 Director of the Cardiac Catheterization Lab, University of Texas Health Science Center at Tyler

5/2000 – 8/2010 Medical Staff – The University of Texas Health Science Center at Tyler, Tyler, Texas

ABIM Board Certified in Interventional Cardiology in 1999 – Recertified through 2019

ABIM Board Certified in Cardiovascular Disease in 1998 – Recertified through 2018

ABIM Board Certified in Internal Medicine in 1995 – Recertified through 2015

APPI Certified Physician Investigator - Recertified through 2011

Federation Licensure Examination

ECFMG Standard Certificate

Fellow, College of Physicians and Surgeons, Pakistan (FCPS-I)
2007 Journal of the College of Physicians and Surgeons Pakistan

2002 – 2003 The American Journal of Cardiology

2002 Catheterization and Cardiovascular Intervention

2004 – 2006 President – Smith County Division of American Heart Association

2003 – Present Member, Board of Directors – Smith County Division of American Heart Association

2000 – 2001 Member, Board of Directors – Titus County Division of American Heart Association

Masroor A. Khan, Ming Liu, D. Singh, Ashish Pal, Francisco Chio, David Lawson, Larry S. Dean. Long Term (3 Years) Effect of Estrogen  Replacement Therapy on Major Adverse Cardiac  Events in Postmenopausal Women after Intracoronary Stenting. American Journal of Cardiology. 2000;86:330 – 333.

Masroor A. Khan, Ming Liu, Francisco Chio, Virginia Yates, Gregory Chapman, Vijay Misra, Araceli Sweeney, Larry Dean. The Effect of Abciximab on Cardiac Enzyme Elevation after Transluminal Extraction Atherectomy (TEC) of High-Risk Saphenous Vein Graft Lesions: Comparison With A Historical Control Group. Cathet.. Cardiovasc. Intervent. 2001 Jan; 52(1): 40 – 44.

Francisco Chio, Ming W. Liu, Shukri M. Al-Saif, Masroor A. Khan, David Lawson, Nadim Al-Mubarak. Long-Term Clinical Outcome after Implantation of Medium Palmaz (biliary) Stents in Very Large Native Coronary Arteries. Cathet.. Cardiovasc. Intervent. 2002 May; 56(1): 35 – 39. 

Masroor A. Khan, Mark A. Hlatky, Ming W. Liu, Feng Lin, William J. Rogers, Michael G. Shlipak, for the HERS Investigators.Effect of Postmenopausal Hormone Therapy on Coronary Heart Disease Events after Percutaneous Transluminal Coronary Angioplasty. The American Journal of Cardiology, 2003 April 15;989-991.

Masroor Khan, Ming Liu, Francisco Chio, Gary Roubin, Sriram Iyer, Jiri Vitek. Predictors of Restenosis after Successful Carotid Stenting. The American Journal of Cardiology, 2003 October 1;895-897.

Francisco L. Chio, Jr., Ming W. Liu, Masroor A. Khan, Sriram S. Iyer, Gary S. Roubin. Effectiveness of Elective Stenting of Common Carotid Artery Lesions in Preventing Stroke. The American Journal of Cardiology, 2003 November 1;1135 – 1137.
 

Masroor A. Khan, MD, FACC, FSCAI

 
Medical Education:

1990       MBBS – Dow Medical College, Karachi, Pakistan.

  • Honors in Biochemistry and Pharmacology
  • Ranked top 2% in class of 450
  • Certificate of Merit for Academic Excellence in Medical School

Postgraduate Training:

7/1998 – 6/1999     Interventional Cardiology Fellowship, University of Alabama at Birmingham
                                                                                                                      
7/1995 – 6/1998     Cardiology Fellowship, Illinois Masonic Medical Center, Chicago, IL
                                                                
7/1992 – 6/1995     Internal Medicine Residency, Wayne State University, Detroit, MI
                                                                 
10/1990 – 9/1991                  Internship in Medicine & Surgery, Civil Hospital, Karachi, Pakistan

Faculty Appointments:

12/2005 – 08/2010   Associate Professor of Medicine, University of Texas Health Science Center at Tyler

5/2000 – 12/2005   Assistant Professor of Medicine, University of Texas Health Science Center at Tyler

8/1998 – 4/2000     Associate Fellow, University of Alabama at Birmingham

Hospital Appointments:
9/2010 – Present      Memorial Herman Medical Center, Houston, Texas

9/2010 – Present      Park Plaza Hospital, Houston, Texas

9/2010 – Present    The Methodist Hospital, Houston, Texas

9/2010 – Present    St. Lukes Episcopal Hosptial, Houston, Texas

1/2006 – 8/2010     Director of the Cardiac Catheterization Lab, University of Texas Health Science Center at Tyler 

5/2000 – 8/2010     Medical Staff – The University of Texas Health Science Center at Tyler, Tyler, Texas

6/2007 – 8/2010     Medical Staff – Trinity Mother Frances Hospital, Tyler, Texas

6/2006 – 12/2008    Medical Staff – ETMC Gilmer, Gilmer, Texas

5/2000 – 6/2006    Medical Staff – Titus Regional Medical Center, Mt. Pleasant, Texas

8/1998 – 4/2000     Medical Staff – University Hospital, University of Alabama at Birmingham, Birmingham, Alabama

Certifications:
           
ABIM Board Certified in Interventional Cardiology in 1999 – Recertified through 2019 
ABIM Board Certified in Cardiovascular Disease in 1998 – Recertified through 2018
ABIM Board Certified in Internal Medicine in 1995 – Recertified through 2015
APPI Certified Physician Investigator  - Recertified through 2011
Federation Licensure Examination
ECFMG Standard Certificate
Fellow, College of Physicians and Surgeons, Pakistan (FCPS-I).

Licensure:

Texas                                                     Alabama (Inactive)
Illinois (Inactive)                                 Kentucky (Inactive)
Michigan (Inactive)                     West Virginia (Inactive)   

Teaching Responsibilities:
                                            
2000 - 2010          Family Medicine residents on one-month Cardiology rotation

2001 – 2010         Cardiology Grand Rounds presented to Family Medicine residents twice each month

Service on UTHSCT Committees:    

2008 – 2011             MSRDP Board Meeting (3-year term)

11/2008 – 11/2011  Promotions Committee (3-year term)       

Editorial Consultant:

2007                          Journal of the College of Physicians and Surgeons Pakistan

2002 – 2003            The American Journal of Cardiology
                                       
2002                          Catheterization and Cardiovascular Intervention

Community Service:

2004 – 2006            President – Smith County Division of American Heart Association

2003 – Present        Member, Board of Directors – Smith County Division of American Heart Association

2000 – 2001            Member, Board of Directors – Titus County Division of American Heart Association

Awards:
                                   
Included in Strathmore’s Who’s Who
Titus County Division of American Heart Association Rookie of the Year 2000-2001
Young Investigator Award – American College of Cardiology, Alabama Chapter 1999 Annual Meeting      
Recognized by US News & World Report as one of the top cardiologists

Invited Lectures:

June 2009             Appropriate Criteria for Non-Invasive Cardiac Tests, Grand Rounds, UTHSCT, Tyler, TX

February 2008     Myocardial Ischemia Redefined:  Optimal Care in CAD, Semi-Annual CME Meeting, Carthage, TX

April 2006             Cardiology Update, University of Texas Health Science Center, Tyler, TX

 

Educational Courses Attended:

June 2010             Nuclear Cardiology Board Examination Preparation Course, American Society of Nuclear Cardiology,
                                Denver, CO

January 2010       IVC Filter Workshop:  Four hours of didactic and three hours of  hands-on training, St. Joseph’s Translational  Research Institute, Atlanta, GA

July 2009              Advances in Peripheral Technique:  A Gloves-On Peripheral Interventions 2-Day Program (2009)   Texas Health Presbyterian Hospital, Dallas, TX
 
November 2007   SCAI 3-Tiered Carotid Artery Stenting Training Program, Emory University School of Medicine, Atlanta, GA             

February 2007     Peripheral Endovascular Training Program/ Boston Scientific Peripheral Vascular Preceptor Workshop, Texas Heart Institute, Houston, TX
               
February 2007     Boston Scientific Peripheral Vascular Preceptor Workshop
                                Texas Heart Institute, Houston, TX                                                               
               
January 2007       Cardiac CT Angiography “Hands-On” Training/Fellowship (Level II Certification) – The Heart Center, Huntsville, AL

September 2006  SCAI Carotid Stenting – Online Phase II Training, The Society for Cardiovascular Angiography and Interventions

February 2006     Cardiac CT Angiography “Hands-On” Training – Level I Certification by American Society of Nuclear Cardiology, Newport Beach, CA

October 2005       TCT 2005 – Transcatheter Cardiovascular Therapeutics, New York, NY 
               
September 2005  Core Curriculum in Carotid Stenting by the Society for Cardiovascular Angiography and Interventions
                                San Francisco, CA

March 2004          State of the Art Carotid Artery Stenting Course by American College of Cardiology, Miami, FL
               
July 1999              New Devices Seminar for the Cardiac and Peripheral Vascular Laboratories,  Orlando, FL

April 1999             Ochsner Peripheral Angioplasty Course, New Orleans, LA

1998                       Nuclear Medical Education, 200 Hour Accredited Nuclear Medical Education Program, Institute for Nuclear Medical Education

Professional Associations:

American College of Cardiology – Fellow
Society of Cardiac Angiography and Intervention – Fellow
Society of Cardiovascular Computed Tomography – Founding Physician
American Society of Nuclear Cardiology
Academy of Pharmaceutical Physicians and Investigators
American College of Physician Executives

Clinical Science Research Activities:
   
Principal Investigator:    

A Comparison CS-747 and Clopidogrel in Acute Coronary Syndrome Subjects
Who Are to Undergo Percutaneous Coronary Intervention – TIMI-38
Sponsor: Sanofi-Synthelabo Research, A Division of Sanofi-Synthelabo, Inc.

   
Principal Investigator:   

A Phase III, Double-Blind, Randomized Placebo-Controlled Study, to Evaluate the effects of RO4607381 on Cardiovascular Risk in Stable CHD Patients, with a Documented Recent Acute Coronary Syndrome – NC20971
Sponsor:  Hoffman-LaRoche    

               
   
Principal Investigator:   

Follow-up Serial Infusions of Natrecor (nesiritide) for the Management of
Patients with Heart Failure – FUSION II
Sponsor: Scios, Inc.

   
Principal Investigator:   

A Placebo-Controlled, Double-Blind, Parallel Arm Trial to Assess the Efficacy of  Dronedarone 400 mg bid for the Prevention of Cardiovascular Hospitalization or Death from Any Cause in Patients with Atrial Fibrillation/Atrial Flutter – AF/AFL
Sponsor: Sanofi-Synthelabo Research, A Division of Sanofi-Synthelabo, Inc.

   
Principal Investigator:   

IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE IT) A Multicenter, Double-Blind, Randomized Study to Establish the Clinical Benefit and  Safety of Vytorin (ezetimibe/simvastatin) vs. Simvastatin Monotherapy in High-Risk Patients Presenting with Acute Coronary Syndrome
Sponsor: Schering Plough

   
Co-Investigator: A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and  Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects with Nonvalvular Atrial Fibrillation
   
Co-Investigator:

An International, Randomized, Double-Blind Study Evaluating the Efficacy and Safety of Fondaparinux versus Enoxaparin in the Acute Treatment of Unstable Angina / Non-ST Segment Elevation MI Acute Coronary Syndromes – OASIS 5
Sponsor: Sanofi-Synthelabo Research, A Division of Sanofi-Synthelabo, Inc

   
Co-Investigator:

Omapatrilat Cardiovascular Treatment Assessment versus Enalapril – OCTAVE  Protocol No. CV137-120 (Ver. 8/31/2000 Inc. Amend. 2)
Sponsor: Bristol-Myers Squibb Company

   
Basic Science Research Activities:
     
Department of Cardiology, Laser Research Lab, Wayne State University
Mentor:  J. Richard Spears MD, FACC, Director Laser Research Lab:

Effect of tissue dehydration before Laser Angioplasty.

Compatibility of various materials to be used to decrease restenosis after balloon angioplasty.

Devised the Spectrophotometric Assay for Penicillamine.

 Abstracts Presented:

(i)          Masroor A. Khan, MD, S. Salman Ali, MD, Wai-Fung Cheong Ph.D, G. LeCarpentier, Ph.D, J. Richard Spears, MD. CW ND: YAG Laser Dehydration prior to pulsed Ho: YAG Laser Ablation reduces injury to the arterial wall. Presented at American College of Physicians, Michigan Associates Meeting in May 1995.

                        
(ii)           Masroor Khan, Ming Liu, D. Singh, Ashish Pal, Francisco Chio, David Lawson, Larry  Dean. Estrogen Replacement Therapy Reduces Major Adverse Cardiac Events (MACE) in Postmenopausal Women After Intracoronary Stenting. An Intermediate and Long Term Follow-up. Presented at the American College of Cardiology, Alabama Chapter 1999 Annual Meeting.

(iii)          Masroor Khan, Ming Liu, D. Singh, Ashish Pal, Francisco Chio, David Lawson, Larry Dean. Estrogen Replacement Therapy Reduces Major Adverse Cardiac Events (MACE) in Postmenopausal Women Intracoronary Stenting: A long Term (>3 Years) Follow-Up. Presented at the American College of Cardiology, Annual Meeting 2000. Anaheim, California.

(iii)         Masroor Khan, Ming Liu, Francisco Chio, Virginia Yates, Gregory Chapman, Vijay Misra, Araceli Sweeney, Larry Dean. Effect of Abciximab on Cardiac Enzyme Elevation After Transluminal Extraction Atherectomy  (TEC) of High-Risk Saphenous Vein Graft Lesions – Comparison With a Historical Control  Group. Presented at the Society of Cardiac Angiography and Intervention, Annual Meeting 2000. Charleston, South Carolina.

(iv)          Masroor Khan, Ming Liu, Francisco Chio, Steven Sooudi, Vijay Misra, Gregory Chapman, Larry Dean. Long Term Follow up of Patients with Intracoronary Stenting of Vessels Less Than 2.5 mm. Presented at the Society of Cardiac Angiography and Intervention, Annual Meeting 2000. Charleston, South Carolina.

(vi)          Masroor Khan, Larry Dean, Gregory Chapman, Vijay Misra, Francisco Chio, Ming Liu. In-Hospital and Long-Term Outcome After Stenting Without Predilatation. Presented at the Society of Cardiac Angiography and Intervention, Annual Meeting 2000. Charleston, South Carolina.

(vii)          Masroor Khan, Ming Liu, Francisco Chio, Gary Roubin, Sriram Iyer, Jiri Vitek, Camilo Gomez, Roekchai Tulyapronchote, Vijay Misra, Feroz Padder, Gregory Chapman, Larry Dean. Predictors of Restenosis after Successful Carotid Stenting. Presented at the American Heart Association, Annual Meeting 2000. New Orleans, Louisiana.

(viii)          Masroor Khan, Michael Shlipak, Ming Liu, Feng Lin, Mark Hlatky, William Rogers, for the HERS investigators. Effect of Postmenopausal Hormone Therapy on Coronary Heart Disease Events after Coronary Angioplasty: The HERS Trial. Presented at American College of Cardiology, Annual Meeting 2002. Atlanta, Georgia.

Published Abstracts:

(i)        Masroor Khan, Ming Liu, D. Singh, Ashish Pal, Francisco Chio, David Lawson, Larry Dean. Estrogen Replacement Therapy Reduces Major Adverse Cardiac Events (MACE) in Postmenopausal Women Intracoronary Stenting: A long Term (>3 Years) Follow-Up. University of Alabama at Birmingham. Journal of American College of Cardiology 2000; (Suppl A) 35: 301A.

(ii)        Masroor Khan, Ming Liu, Francisco Chio, Virginia Yates, Gregory Chapman, Vijay Misra, Araceli Sweeney, Larry Dean. Effect of Abciximab on Cardiac Enzyme Elevation After Transluminal Extraction Atherectomy (TEC) of High-Risk Saphenous Vein Graft Lesions – Comparison With a Historical Control Group. University of Alabama at Birmingham. Catheterization and Cardiovascular Interventions 2000; 50:147.

 (iii)         Masroor Khan, Ming Liu, Francisco Chio, Steven Sooudi, Vijay Misra, Gregory Chapman, Larry Dean. Long Term Follow up Of Patients with Intracoronary Stenting of Vessels Less Than 2.5 mm. University of Alabama at Birmingham. Catheterization and Cardiovascular Interventions 2000;50:147.

(iv)          Masroor Khan, Larry Dean, Gregory Chapman, Vijay Misra, Francisco Chio, Ming Liu. In-Hospital and Long-Term Outcome After Stenting Without Predilatation. University of Alabama at Birmingham. Catheterization and Cardiovascular Interventions 2000; 50:147.

(v)         E Francisco Chio, Ming Liu, Masroor Khan, Rokechai Tulyapronchote, Vijay Misra, Gregory Chapman, Diane Alred, Kimberly Kretzer, Virginia Yates, Sriram Iyer*, Gary Roubin*, Camilo Gomez, Larry Dean.lective Stenting of Common Carotid Artery. University of Alabama at Birmingham. *Lenox Hill Heart and Vascular Institute, New York, New York. Catheterization and Cardiovascular Interventions 2000; 50:147.

(vi)          Masroor Khan, Ming Liu, Francisco Chio, Gary Roubin, Sriram Iyer, Jiri Vitek, Camilo Gomez, Roekchai Tulyapronchote, Vijay Misra, Feroz Padder, Gregory Chapman, Larry Dean. Predictors of Restenosis after Successful Carotid Stenting. University of Alabama at Birmingham. Circulation 2000

(vii)         Ming W. Liu, Francisco Chio, Masroor A. Khan, Jain F. Luo, Diane Alred. Local Alcohol Delivery in Coronary Arteries May Prevent Repeat In-Stent Restenosis. University of Alabama at Birmingham.
Journal of American College of Cardiology 2001; (Suppl A) 37: 13A

(viii)        Partha Manchikalapudi, Masroor Khan, Ramin Arani, Vijay Misra, Ming Liu, Gregory Chapman, Suzanne Oparil, Larry Dean. Estrogen Use is Associated With Reduced Need For Target Lesion Revascularization in Postmenopausal Women After Coronary Stenting. UAB Medical Center, Birmingham, Alabama. Journal of American College of Cardiology 2001; (Suppl A) 37: 81A.

(ix)     Masroor Khan, Michael Shlipak, Ming Liu, Feng Lin, Mark Hlatky, William Rogers, for the HERS investigators. Effect of Postmenopausal Hormone Therapy on Coronary Heart Disease Events after  Coronary Angioplasty: The HERS Trial. Journal of American College of Cardiology 2002; (Suppl A) 39 : 56A.

Published Manuscripts:

  1. Masroor A. Khan, Ming Liu, D. Singh, Ashish Pal, Francisco Chio, David Lawson, Larry S. Dean. Long Term (3 Years) Effect of Estrogen  Replacement Therapy on Major Adverse Cardiac  Events in Postmenopausal Women after Intracoronary Stenting. American Journal of Cardiology. 2000;86:330 – 333.

  2. Masroor A. Khan, Ming Liu, Francisco Chio, Virginia Yates, Gregory Chapman, Vijay Misra, Araceli Sweeney, Larry Dean. The Effect of Abciximab on Cardiac Enzyme Elevation after Transluminal Extraction Atherectomy (TEC) of High-Risk Saphenous Vein Graft Lesions: Comparison With A Historical Control Group. Cathet.. Cardiovasc. Intervent. 2001 Jan; 52(1): 40 – 44.

  3. Francisco Chio, Ming W. Liu, Shukri M. Al-Saif, Masroor A. Khan, David Lawson, Nadim Al-Mubarak. Long-Term Clinical Outcome after Implantation of Medium Palmaz (biliary) Stents in Very Large Native Coronary Arteries. Cathet.. Cardiovasc. Intervent. 2002 May; 56(1): 35 – 39. 

  4. Masroor A. Khan, Mark A. Hlatky, Ming W. Liu, Feng Lin, William J. Rogers, Michael G. Shlipak, for the HERS Investigators.Effect of Postmenopausal Hormone Therapy on Coronary Heart Disease Events after Percutaneous Transluminal Coronary Angioplasty. The American Journal of Cardiology, 2003 April 15;989-991.
  5. Masroor Khan, Ming Liu, Francisco Chio, Gary Roubin, Sriram Iyer, Jiri Vitek. Predictors of Restenosis after Successful Carotid Stenting. The American Journal of Cardiology, 2003 October 1;895-897.
                                
  6. Francisco L. Chio, Jr., Ming W. Liu, Masroor A. Khan, Sriram S. Iyer, Gary S. Roubin. Effectiveness of Elective Stenting of Common Carotid Artery Lesions in Preventing Stroke. The American Journal of Cardiology, 2003 November 1;1135 – 1137.